Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

170.80
+2.641.57%
Volume:3.56M
Turnover:604.85M
Market Cap:44.07B
PE:-12.01
High:171.04
Open:167.66
Low:167.52
Close:168.16
52wk High:176.60
52wk Low:141.05
Shares:258.02M
Float Shares:258.02M
Volume Ratio:0.56
T/O Rate:1.38%
Dividend:2.45
Dividend Rate:1.43%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.28
PE(LYR):-12.01

Loading ...

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Amid Jobs Data

MT Newswires Live
·
Oct 02

Analyst Initiates Buy on GPI, Citing Strong Earnings Quality, Margin Resilience and Long-Term Growth Visibility in Software and Healthcare Solutions

TIPRANKS
·
Oct 02

Health Care Select Sector SPDR: Pivot points

TIPRANKS
·
Oct 02

Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Oct 02

Correction: Top Midday Decliners

MT Newswires Live
·
Oct 02

Piper Sandler Remains a Buy on Shattuck Labs (STTK)

TIPRANKS
·
Oct 02

Piper Sandler Remains a Buy on Regeneron (REGN)

TIPRANKS
·
Oct 02

EPF Raises Stake in IHH Healthcare to 13.245%

TIPRANKS
·
Oct 02

Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Atricure (ATRC)

TIPRANKS
·
Oct 02

Johnson & Johnson announces two-year data from Phase 3 ICONIC-TOTAL study

TIPRANKS
·
Oct 02

Johnson & Johnson Says Icotyde Sustains Psoriasis Skin Clearance Through 2 Years in Phase 3 Iconic-TOTAL Study

Reuters
·
Oct 02

J&J - Icotyde-Treated Patients Show 70% Clear or Almost Clear Skin at Week 112

THOMSON REUTERS
·
Oct 02

Johnson & Johnson Announces New Icotyde® (Icotrokinra) Data in Difficult-to-Treat Plaque Psoriasis with Proven Durability Through 2-Years, Affirming Its Use as a Powerful First Line Systemic Therapy~

THOMSON REUTERS
·
Oct 02

J&J - 60% Scalp Psoriasis, 89% Genital Psoriasis Patients Achieve Complete Clearance at Week 112

THOMSON REUTERS
·
Oct 02

J&J - Safety Findings Through Week 112 Consistent with Icotyde Profile, no New Safety Signals

THOMSON REUTERS
·
Oct 02

Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), Liquidia Technologies (LQDA) and Abbott Laboratories (ABT)

TIPRANKS
·
Oct 02

Man Group PLC : Form 8.3 - Spire Healthcare Group Plc

GlobeNewswire
·
Oct 02

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Oct 02

Honliv Healthcare advances probe, control review in push to resume HK trading

TIPRANKS
·
Oct 02

Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals

Dow Jones
·
Oct 02